30th July 2025
We’re pleased to announce the publication of the PROMPPT feasibility study in the journal Pilot and Feasibility Studies.
The study explored the acceptability and feasibility of the PROMPPT review—a pharmacist-led intervention in primary care for people prescribed opioids for persistent non-cancer pain.
The study demonstrated that PROMPPT is both acceptable to patients and feasible to deliver in primary care, paving the way for a large-scale cluster randomised controlled trial.
